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Abstract This study compares gender differences in
Healthy Life Years (HLY) and unhealthy life years (ULY)
between the original (EU15) and new member states
(EU10). Based on the number of deaths, population and
prevalence of activity limitations from the Statistics of
Living and Income Conditions Survey (SILC) survey, we
calculated HLY and ULY for the EU10 and EU15 in 2006
with the Sullivan method. We used decomposition analysis
to assess the contributions of mortality and disability and
age to gender differences in HLY and ULY. HLY at age 15
for women in the EU10 were 3.1 years more than those for
men at the same age, whereas HLY did not differ by gender
in the EU15. In both populations ULY at age 15 for women
exceeded those for men by 5.5 years. Decomposition
showed that EU10 women had more HLY because higher
disability in women only partially offset (-0.8 years) the
effect of lower mortality (?3.9 years). In the EU15
women’s higher disability prevalence almost completely
offset women’s lower mortality. The 5.3 fewer ULY in
EU10 men than in EU10 women mainly reﬂected higher
male mortality (4.5 years), while the fewer ULY in EU15
men than in EU15 women reﬂected both higher male
mortality (2.9 years) and higher female disability
(2.6 years). The absence of a clear gender gap in HLY in
the EU15 thus masked important gender differences in
mortality and disability. The similar size of the gender gap
in ULY in the EU-10 and EU-15 masked the more unfa-
vourable health situation of EU10 men, in particular the
much stronger and younger mortality disadvantage in
combination with the virtually absent disability advantage
below age 65 in men.
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Introduction
Women live longer than men. This is not a new phenom-
enon as in the eighteenth century when time series on life
expectancy began in Sweden, a gender difference in life
expectancy at birth of almost 3 years in favour of women
was found (Human Mortality Database 2010, http://www.
mortality.org/). Similar gender gaps were present in
European countries where time series started in the nine-
teenth century (France, Denmark, Netherlands, Belgium
and Norway), except for Belgium where life expectancy at
birth of men and women was equal (Human Mortality
Database 2010, http://www.mortality.org/). In the course of
the twentieth century, the overall mortality reduction was
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DOI 10.1007/s10433-010-0169-xmore beneﬁcial for women and resulted in a substantial
widening of the male–female longevity gap. In the low
mortality countries, this tendency has reversed in the last
decades (European Observatory on the Social Situation—
Demography Network 2009b). Until today, life expectancy
of women exceeds that of men, although the size of the
gender gap varies between populations (Jagger et al. 2008;
Commission of the European Communities 2009).
The longer life expectancy of women may suggest that
women are healthier than men. However, substantial evi-
dence exists that women report worse self-rated health,
more health problems, more frequent disability and use
more health services, both in terms of hospitalisation
and medications than same-aged men throughout life
(Verbrugge 1989; Crimmins et al. 1996; Leveille et al.
2000; Case and Paxson 2005; Oksuzyan et al. 2008, 2009).
This mortality advantage and health disadvantage is known
as the ‘health-survival’ paradox (Oksuzyan et al. 2008). For
a comprehensive assessment of health, in particular gender
differences in health, it is important to consider both
survival and health, rather than looking at either life
expectancy or the health status of the population.
Health expectancy indicators, that combine mortality
and morbidity data into a single composite indicator, are
increasingly used to assess the health of populations or
population groups (Robine et al. 1992, 2003; Robine and
Jagger 2003). Health expectancy indicators share important
attractive properties with life expectancy, such as their
measurement in expected years of life and their indepen-
dence from the age structure of the population, if small age
intervals are used. An additional attractive feature is that
health expectancy takes into account both mortality and the
health status of the surviving population and thus provides
information on the length of life (adding years to life), and
the healthfulness of life (adding life to years). A well-
known example is the disability-free life expectancy
(DFLE). DFLE indicates how many years of the total life
expectancy a person of a given age can expect to live
without disability, and the difference between the total life
expectancy and the DFLE is the life expectancy with dis-
ability. Different variants of DFLE exist, depending on
how disability is measured.
Healthy Life Years (HLY) or the expected life years
without activity limitations, which was selected in 2004 to
be one of the structural indicators of the EU (European
Commission 2010), combines information on mortality
with disability based on the global activity limitation index
(GALI). The GALI aims to capture long-term limitation (at
least 6 months) in usual activities, caused by ill-health and
includes three severity levels: not limited, limited but not
severely, and severely limited (Van Oyen et al. 2006).
Detailed information on Health Expectancies in Europe,
including HLY for all EU member states is available from
the European Health Expectancy Monitoring Unit (http://
www.ehemu.eu/) and the general public website devoted to
HLY (http://www.healthy-life-years.eu/). HLY differ sub-
stantially between EU member states and within member
states (e.g., between men and women). Most striking is the
gap between the original (EU15) member states (Austria,
Belgium, Denmark, Finland, France, Germany, Greece,
Ireland, Italy, Luxembourg, the Netherlands, Portugal,
Spain, Sweden and United Kingdom) and the new EU
(EU10) member states that joined after 2004 (Cyprus,
Czech Republic, Estonia, Hungary, Latvia, Lithuania,
Malta, Poland, Slovakia and Slovenia). HLY in women at
age 50 were 1.5 years lower in the pooled EU10 countries
than in the pooled EU15 countries, and this disadvantage
was 3 years in men (Jagger et al. 2008).
Reducing inequalities in HLY within member states
receives high priority on the EU (European Commission
2009) and national policy agendas (VWS 2008), both from
an equity point of view and because improving health of
the disadvantaged group may improve health of the pop-
ulation at large. To reduce inequalities, insight is needed
into the underlying causes of the inequalities, as these may
point at possible interventions, either at the societal or the
individual level, to reduce them. A ﬁrst step is assessing to
what extent differences in HLY are due to differences in
mortality and disability, and at which ages these differ-
ences occur. In mortality research, decomposition (i.e.,
partitioning) techniques have been widely used to assess
the contribution that age groups make to differences in life
expectancy (Arriaga 1984; Pollard 1988) including gender
disparities in life expectancy (Bah 1998; Trovato and Lalu
1998; Nusselder and Looman 2004). Similar tools are now
available to partition differences in health expectancy into
additive contributions of mortality versus disability dif-
ferences and of age groups (Andreev et al. 2002; Nusselder
and Looman 2004). For the Netherlands, using these tools
has revealed that DFLE did not differ between men and
women because the effect of higher prevalence of disability
in women, reducing DFLE, and lower mortality, increasing
DFLE, largely compensated each other (Nusselder and
Looman 2004). But the same study also showed that due to
the combination of the higher prevalence of disability and
lower mortality women spent substantially more years with
disability than men.
The aim of the current study is to describe and compare
gender differences in HLY and unhealthy life years (ULY),
deﬁned as the expected life years with activity limitations,
in the pooled EU10 and EU15 populations, and to explain
differences in the overall patterns by looking at the con-
tribution of mortality and disability differences and of
different age groups.
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Data
We obtained age and sex-speciﬁc data on the number of
deaths (2006), the population (2006, 2007) and prevalence
of activity limitation (2006) for each EU member state
from the European Health Expectancy Monitoring Unit
(EHEMU) Information System (http://www.ehemu.eu/).
Death counts and population estimates for each member
state originate from the EUROSTAT database (http://epp.
eurostat.ec.europa.eu/), except for France and Italy where
death counts were directly collected by EHEMU from
the national statistical ofﬁces (INSEE and ISTAT,
respectively).
The number of persons with activity limitations and total
numbers in the sample by age, sex for each member state
were derived by EHEMU from the Statistics of Living and
Income Conditions Survey (SILC) in 2006. The SILC
survey was ﬁrst conducted in all EU25 countries in 2005,
on individuals aged 16 years and over. The cross-sectional
SILC that was used for this study was based on nationally
representative probability samples of the population
residing in private households within the country, irre-
spective of language or nationality. The SILC survey in
2006 covers a sample in total of 375,243 participants
(235,835 in EU15 and 139,408 in EU10), of which 369 633
responded to the GALI question (233 391 in EU15 and 136
242 EU10). Overall non-response rate averaged over
countries is somewhat above 20%. There is a large varia-
tion around this average among the countries, with the
non-response rate varying from 5% in Cyprus to 40% in
Denmark and Belgium (EUROSTAT 2009). What distin-
guishes EU-SILC from prior EU surveys, such as the
European Community Household Panel (ECHP), is its
organisation under a framework Regulation instead of a
gentlemen’s agreement. This implies that the survey is
compulsory for all EU Member States, and is based on a
common ‘framework’, which is deﬁned by: harmonised
lists of target variables, a recommended design for imple-
menting EU-SILC, common requirements for imputation,
weighting, sampling error calculation, and common con-
cepts (household and income) and classiﬁcations (Eurostat
2007). For more information on EU-SILC, see: http://circa.
europa.eu/Public/irc/dsis/eusilc/library.
Activity limitation
SILC contains the Minimum European Health Module
(MEHM), devised by the Euro-REVES group (Robine and
Jagger 2003), which includes a disability measure, the
global activity limitation index (GALI). The GALI
instrument (‘For at least the last 6 months, have you been
limited because of a health problem in activities people
usually do?’) aims to capture long-term limitation
([6 months) in usual activities, caused by ill-health with
three severity levels: none, limited but not severely and
severely limited (except for Denmark where there were
only two response categories: limited or not). The reli-
ability and validity of the GALI have already been reported
(Van Oyen et al. 2006; Cox et al. 2009; Jagger et al. 2010),
respectively. People were considered to be disabled
(unhealthy) in our study, when they reported any limitation
(not severely and severely).
EU10 versus EU15
We divided the EU member states into two groups: EU15,
including EU member states before May 2004 and EU10,
including the new member states joining the EU in May
2004. The EU15 consists of: Austria (AT), Belgium (BE),
Denmark (DK), Finland (FI), France (FR), Germany
(DE), Greece (GR), Ireland (IE), Italy (IT), Luxembourg
(LU), the Netherlands (NL), Portugal (PT), Spain (ES),
Sweden (SW) and United Kingdom (UK). The EU 10
consists of: Cyprus (CY), Czech Republic (CZ), Estonia
(ET), Hungary (HU), Latvia (LV), Lithuania (LT), Malta
(MT), Poland (PL) Slovakia (SK) and Slovenia (SL).
Romania and Bulgaria were not included because they did
not join the EU until 2007.
Methods
Sullivan life table analyses
HLY is the number of years a person of a given age can
expect to live free of activity limitations. For each gender
and for the pooled EU10 and EU15 populations separately,
the HLY indicator was calculated using Sullivan’s method
(Sullivan 1971; Jagger 1999). The Sullivan method uses
the prevalence of disability in each age group to divide the
number of person-years into years with and without dis-
ability (Jagger 1999). The number of person-years by age
was calculated from age-speciﬁc mortality rates using
standard life table techniques, assuming that deaths occur
on average in the middle of the age interval (linear
assumption). Multiplying the number of person-years in
each age group with the proportion disabled in that age
group gives the number of person-years in each age group
with disability. Summing the number of person-years with
disability from the age ‘a’ at which the life expectancy is
calculated until the last age group gives the total number of
years lived with disability lived after age ‘a’. Dividing this
number by the total number of persons alive at age ‘a’
gives the ULY at age ‘a’. The number of HLY is obtained
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using 1 minus the proportion disabled in the above men-
tioned approach). It is noteworthy that each age group
contributes to the number of disabled years, although older
age groups, where the prevalence of disability is higher,
contribute more than younger age groups. We present HLY
and ULY, and their sum the total life expectancy (LE) at
age 15, 50 and 65 years.
Decomposition analysis
The contribution of the mortality and disability effects,
and of different age groups, are assessed by using a
decomposition tool which partitions the gender differ-
ences in health expectancy into additive contributions
(Nusselder and Looman 2004). This technique is based on
the Sullivan method to calculate health expectancy and is
an extension of the Arriaga method (Arriaga 1984)t o
decompose differences in total life expectancy. The
decomposition tool ﬁrst decomposes the difference (or
change) in health expectancy at age ‘a’ into mortality and
disability effects. The mortality effect is the difference in
health expectancy due to a difference in the number of
person-years lived caused by a difference in total mor-
tality up to and including that age. The disability effect is
the difference in health expectancy due a change in the
proportion with disability. The mortality effect is further
decomposed by age using an adjustment of the Arriaga
method. If data on disability and mortality by cause are
available, further decomposition by cause is possible with
the tool. The decomposition tool is described in more
detail elsewhere (Nusselder and Looman 2004). All
analyses were performed in R (http://www.r-project.org/).
User-friendly software for decomposition of differences in
life and health expectancy by age, mortality and disability
and causes of death and disability is available from the
author on request.
Results
LE, HLY and ULY at age 15, 50 and 65
in the EU10 and EU15
In the EU15 women aged 15 could expect to live a further
68.5 years, of which 48.4 years (71% of their remaining
life expectancy) were free of activity limitation, whilst
HLY at age 15 for men were 48.4 years, 77% of their
remaining life expectancy of 62.9 years (Table 1). ULY at
age 15 were 20.1 years for women and 14.6 years for men
in the EU15. The health picture for the EU10 was sub-
stantially less favourable than for the EU15. In the EU10,
women aged 15 could expect to live a further 64.7 years, of
which 45.8 years (71%) were free of activity limitations,
whilst HLY for men in the EU10 were 42.7 years (76%
of their remaining life expectancy of 56.3 years). ULY at
age 15 in the EU10 were 18.9 years for women and
13.6 years for men. The EU10 disadvantage was also
present at older ages (Table 1), indicating systematic dif-
ferences in life and health expectancies between the EU10
and EU15 populations.
Gender differences in HLY
The pooled EU10 population not only had worse health
compared to the pooled EU15 population, but gender dif-
ferences were also larger. HLY at age 15 for women in the
EU10 exceeded those of men of the same age by 3.1 years,
while in the EU15 HLY at age 15 did not differ between
men and women. At age 50 and age 65, the gender gaps in
HLY were still small in the EU15 (0.2 years at age 50 and
0.2 years at age 65) whilst in the EU10 they decreased
from 3.1 years at age 15, to 1.7 years at age 50 and
0.4 years at age 65.
Decomposition of the gender gap in HLY partitions the
gender difference into the contribution made by differences
in mortality and by differences in the prevalence of
Table 1 Healthy Life Years (HLY), Unhealthy Life Years (ULY) and total life expectancy (LE), and proportion of life expectancy spent free of
disability (% HLY/LE) at age 15, 50 and 65
Age 15 Age 50 Age 65
HLY
(years)
ULY
(years)
LE
(years)
HLY/LE
(%)
HLY
(years)
ULY
(years)
LE
(years)
HLY/LE
(%)
HLY
(years)
ULY
(years)
LE
(years)
HLY/LE
(%)
EU15 men 48.4 14.6 62.9 76.9 18.4 11.4 29.8 61.6 9.0 8.5 17.5 51.5
EU15 women 48.4 20.1 68.5 70.7 18.6 15.9 34.5 53.9 9.2 11.9 21.1 43.7
Difference 0.0 5.5 5.5 -6.2 0.2 4.4 4.7 -7.7 0.2 3.4 3.6 -7.8
EU10 men 42.7 13.6 56.3 75.8 13.8 10.7 24.5 56.2 6.4 7.8 14.3 45.0
EU10 women 45.8 18.9 64.7 70.8 15.5 15.5 31.0 50.0 6.9 11.5 18.4 37.4
Difference 3.1 5.3 8.4 -5.0 1.7 4.8 6.5 -6.3 0.4 3.7 4.1 –7.7
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123disability. It shows that the 3.1 extra HLY that women in
the EU10 could expect to live compared to men were lar-
gely caused by women’s lower mortality (?3.9 HLY)
(Table 2). Women lived longer and, ceteris paribus, lived
longer free of disability. But also the age-speciﬁc preva-
lence of disability in women was higher than in men. This
yielded 0.8 fewer HLY. In the EU15, the effect of women’s
lower mortality (increasing HLY by 2.6 years) was almost
completely nulliﬁed by the higher disability prevalence
(reducing HLY by 2.6 years); hence the number of HLY
was similar for EU15 men and women.
The gender gap in HLY reduced with increasing age in
the EU10 (Fig. 1a), reﬂecting a decreasing mortality effect
in contrast to the disability effect, which did not decrease
with age. In the EU15, both the disability and mortality
effects decreased gradually with age.
Gender differences in ULY
In both the pooled EU10 and EU15 populations, for women
at age 15 ULY were 5.5 years more than for men
(Table 1). At older ages the gender gap in ULY was also
similar in the EU10 and EU15; at age 50, the gap was
4.8 years in the EU10 and 4.4 years in the EU15 and at age
60 3.7 and 3.4 years, respectively (Table 1).
Decomposition of gender differences in ULY showed
that the contribution of the mortality and disability effects
differed substantially between the EU10 and EU15 popu-
lations. At age 15, the gender gap in ULY in the EU10 was
mainly the result of men’s higher mortality (4.5 years)
whilst their lower disability only explained 0.8 fewer ULY
(Table 2). In the EU15, men also lived 5.5 fewer ULY than
women, but in this population the lower ULY reﬂected a
combination of higher mortality (2.9 years) and lower
Table 2 Decomposition of the gender gap in Healthy Life Years
(HLY), Unhealthy Life Years (ULY) and total life expectancy (LE)
by effect, at age 15 for men and women
Age 15 EU15 EU10
HLY ULY LE HLY ULY LE
Men 48.4 14.6 62.9 42.7 13.6 56.3
Women 48.4 20.1 68.5 45.8 18.9 64.7
Difference
Women–Men 0.02 5.5 5.5 3.1 5.3 8.4
Decomposition of difference
Mortality effect 2.6 2.9 5.5 3.9 4.5 8.4
Disability effect -2.6 2.6 0.0 -0.8 0.8 0.0
Total 0.02 5.5 5.5 3.1 5.3 8.4
age 15
age 50
age 65
eu-15
age 15
age 50
age 65
Mortality Disability Total
-4 -2 0 2 4 6
-4 -2 0 2 4 6
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Fig. 1 a Decomposition of the
gender gap in Healthy Live
Years (HLY) at age 15, 50 and
65 into mortality and disability
effects in pooled EU15 and
EU10 populations.
b Decomposition of gender gap
in Unhealthy Live Years (ULY)
at age 15, 50 and 65 into
mortality and disability effect in
pooled EU15 and EU10
populations
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123disability (2.6 years) in men. At older ages the patterns
were similar to younger ages (Fig. 1b).
Comparison of the contribution of different age groups
to the gender differences in ULY, and the mortality and
disability effects between the EU10 and EU15 populations,
showed a disability advantage in EU15 men at all ages,
while for the EU10 this was seen only at older ages
(Fig. 2b). In addition the mortality disadvantage in EU10
men occurred at younger ages than in the EU15 population.
Discussion
Both in the pooled EU10 and EU15 populations, women
live longer than men, but women also spend more years
and a larger proportion of their remaining life expectancy
with disability. The gender gap in HLY, however, differs
between the two populations. While in the EU15 popula-
tion the gender gap in HLY is virtually absent, it is more
than 3 years in the EU10 population. Our study thus shows
that the health-survival paradox is present in both the EU10
and EU15 populations, but it also points at clear
differences in the overall patterns of the gender gaps. In the
EU10 the male mortality disadvantage is larger. Addi-
tionally, the commonly found disability advantage in men
appears to be much smaller in EU10 males, and is virtually
absent below age 65. Hence EU10 males face a double
disadvantage: higher mortality than EU10 females and
EU15 males and a smaller disability advantage than EU15
males. As a result, EU10 men not only have a shorter total
life expectancy, but also the number of HLY is substan-
tially lower than in women of the same age. In the EU15
population, this male disadvantage in HLY is not found.
A potential limitation of our study relates to using self-
reported disability data from one single question in surveys
of the non-institutionalised population. As medical or other
registrations generally do not include information on
disability, surveys are the standard source of disability
information. Disability in large-scale surveys is mostly
self-reported; only a few surveys and none that are across
all EU countries include performance-based measures of
disability. Relying on self-reports of disability may have
biased our results, in particular because reporting behav-
iour may differ between men and women. However,
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Fig. 2 a Decomposition of the
gender gap in Unhealthy Live
Years (ULY) at age 15 into
mortality and disability effects
and by age, pooled EU15
population. b Decomposition of
the gender gap in Unhealthy
Live Years (ULY) at age 15 into
mortality and disability effects
and by age, pooled EU10
population
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123comparing self-reports with performance measures con-
ﬁrms that women are truly more disabled than men (Merrill
et al. 1997).
Using one single question to assess disability may have
introduced bias, although we expect this to be less than
that from using all non-harmonised disability measures,
particularly since a previous validation study showed that
the GALI question has an acceptable reliability (Cox et al.
2009). In addition, another recent study comparing the
GALI with other disability measures, showed that the
GALI appears to satisfactorily reﬂect levels of function
and disability as assessed by longer-standing objective and
subjective measures, both across Europe and in a similar
way between countries (Jagger et al. 2010). The interna-
tional comparability of the disability measures in our study
is better than earlier efforts to obtain EU wide disability
measures, including the ECHP. However, the SILC
2006 is still not fully comparable between the countries
(Ekholm and Bronnum-Hansen 2009). In particular for
Germany and Denmark the GALI question is not compa-
rable to those in other countries. We reran our analyses
excluding these two countries, but found no differences in
our results. Excluding the institutionalised population may
also have affected our results, as the rate of institution-
alisation is known to differ by gender. However, given the
higher institutionalisation rate in women, we expect that if
anything, our conclusion on the double disadvantage in
EU10 men as compared to EU10 women would become
stronger if we had included data among the institutiona-
lised population.
Some limitations of the methods need to be considered.
The calculation of HLY and the decomposition of HLY are
based on the Sullivan method. The Sullivan method is the
standard way to calculate health expectancy on a routine
basis, however, it does not produce a pure period indicator
such as (period) life expectancy. While the deviation from
a pure period indicator can introduce bias (Barendregt et al.
1994; Van de Water et al. 1995; Mathers and Robine
1997), this should not be important for comparisons
between population groups. Regarding the decomposition
method, it is noteworthy that the tool identiﬁes the extent to
which differences in disability prevalence and total mor-
tality (in each age group) contribute to health expectancy
differences. It cannot assess the contribution of underlying
ﬂows, such as incidence of disability and recovery from
disability (Nusselder and Looman 2004).
Another limitation is that our study treated the pooled
EU10 and EU15 population as homogeneous groups,
ignoring differences between the member states within
each groups (Jagger et al. 2008; Commission of the
European Communities 2009). The results of our study can
therefore not be generalised to speciﬁc member states, but
serves to understand better the overall picture. The next
step will be to assess the variation in gender gaps within
individual member states, and to assess which countries do
and do not ﬁt to the general picture.
Our study conﬁrms the presence of the health-survival
paradox (Case and Paxson 2005; Oksuzyan et al. 2009);
both in the EU10 and EU15 populations women do live
longer but spend more years with disability. There are
different explanations for this paradox. One explanation is
that women are healthier than men, but simply report more
health problems in surveys than men. Possible reasons for
differences in reporting are that women are more likely to
factor less serious ailments into their reports of poor health
(Spiers et al. 2003), or that men are more reluctant to
participate and/or accurately report in surveys if they have
disabilities or diseases (Oksuzyan et al. 2009). There is
substantial evidence that the health-survival paradox is not
just an artefact. For instance, observed performance of
physical tasks conﬁrms that women have more disability
than men of the same age (Merrill et al. 1997). A recent
study of Oksuyan (Oksuzyan et al. 2009) found that the
contribution of selection bias due to lower participation of
men when they have ill-health or disability, is likely to be
small. The same study also found no evidence for sex-
speciﬁc reporting of medication use. The second explana-
tion is that women do have higher morbidity than men, and
explanations include: a negative impact of estrogen and the
second X chromosome, differences in the immune system
to avoid the harmful effects of infections, a relatively
higher compatibility of sick roles with other female
responsibilities, engagement in more risk taking behaviour
among men, as well as better awareness of disease symp-
toms, and timely seeking for medical advice (for an over-
view, see: Oksuzyan et al. 2009). Also the lower peak bone
mass in women, accelerated bone loss beginning at men-
opause and less muscle strength in women may contribute
to gender differences (Leveille et al. 2000). These factors
may have resulted in gender differences in the distributions
of chronic conditions (Verbrugge 1989; Case and Paxson
2005). Women are more likely than men to have non-fatal
diseases, such as arthritis, whereas men are more likely to
have conditions such as cardiovascular disease (CVD) or
respiratory conditions with high case-fatality (Leveille
et al. 2000). Additionally, these factors may have resulted
in men having higher chances of experiencing hospital
episodes and dying from the same chronic conditions,
implying that men may experience more severe forms of
these conditions.
A novel ﬁnding is that the pattern of gender differences
varies between the EU10 and EU15 populations. In par-
ticular, in the EU10 the much stronger and younger mor-
tality disadvantage (of the 8.4 years gap in life expectancy
5.1 years originates below age 65) in men, in combination
with the virtually absent disability advantage below age 65,
Eur J Ageing (2010) 7:219–227 225
123is striking. A possible explanation for this unfavourable
situation is the rapid economic transition in the former
communist states. According to McKee (McKee and
Shkolnikov 2001) young men were especially vulnerable to
the consequences of the policies pursued by the communist
regimes in eastern Europe before 1990 and the ensuing
transition. The leading causes of high mortality in these
countries, in particular among men were injuries and vio-
lence, cardiovascular diseases and cancers (McKee and
Shkolnikov 2001; European Observatory on Social Situa-
tion and Demography 2009a). High levels of alcohol con-
sumption, especially binge drinking, were the main
contributors to the high mortality from these causes in men,
as did smoking and poor nutrition, but to a lesser extent
(McKee and Shkolnikov 2001). Also the lower quality of
medical care in the former Central and Eastern European
Countries may have contributed to the more unfavourable
position of EU10 men. A study of Newey et al. (2003)n o t
only showed a clear gender gap in preventable mortality in
the new member states, but also indicated that treatable
mortality, i.e., from causes that are responsive to medical
intervention, through secondary prevention and treatment,
was higher in men than in women in this region.
Our study has important implications. First, given the
health-survival paradox, gender differences in health
should be assessed by health indicators that take into
account both mortality and morbidity. Additionally both
healthy and unhealthy years need consideration. The gen-
der gap in HLY masks important gender differences in
mortality and disability within the EU15, while the similar
size of the gender gap in ULY in the EU10 and EU15
masks the more unfavourable position of EU10 men, both
due to higher mortality and a smaller disability advantage
as compared to EU10 women and EU15 men. Second, the
dire situation of men in the EU10, in particular below age
65, may have important consequences for their ability to
contribute fully in society, and may preclude men from
participating fully in working life, family life and society.
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